SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences (SLS) is surging as investor anticipation builds over the REGAL Phase 3 trial, with the community actively speculating on a potential buyout and a major short squeeze driven by significant short interest and impending trial milestones. Bulls are pointing to the extended survival data in the clinical trial as evidence of success, while bears maintain concerns regarding trial design, statistical significance, and potential dilution risks.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is seeing volatile trading as investors grapple with the broader semiconductor sector's high valuations and shifting momentum following recent earnings reports from memory-focused peers. The community remains deeply divided, with many traders debating whether recent price swings represent a healthy consolidation phase for a long-term AI play or a broader repricing of the sector as supply-side constraints and rising infrastructure costs impact sentiment.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is seeing heightened volatility and debate as community members speculate on a potential price breakout, while others voice concerns regarding historical pump-and-dump patterns and lack of clear communication from the team. Traders are actively tracking technical indicators and volume spikes, with many discussing the risk-to-reward potential of holding the token amidst ongoing market fluctuations.

Bloom Energy Corp. engages in the manufacture and installation of a solid oxide fuel-cell based power generation platform. Its product, Bloom Energy Server, converts standard low-pressure natural gas or biogas into electricity through an electrochemical process without combustion. The company was founded by K. R. Sridhar, John Finn, Jim McElroy, Matthias Gottmann, and Dien Nguyen on January 18, 2001, and is headquartered in San Jose, CA.

Bloom Energy Corp - Ordinary Shares - Class A

Bloom Energy is currently trending as a primary play within the AI-infrastructure sector, with investors focused on the company's fuel cell technology as a solution to data center power and grid capacity bottlenecks. The community is actively debating the stock's valuation, recent price volatility linked to index rebalancing, and its long-term potential as a critical partner for major hyperscalers.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is currently experiencing significant market volatility driven by an 18% workforce reduction and the departure of its COO, as the company aggressively cuts costs to align with market demand. The community is polarized, with some investors highlighting the potential of the upcoming midsize platform and robotaxi partnerships as long-term catalysts, while many others are expressing deep frustration over persistent price declines, share dilution, and the ongoing struggle to achieve profitability.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential index rebalancing activity and institutional positioning, fueling intense community debate over technical breakouts and the company's long-term clinical pipeline. Traders are closely monitoring heavy volume and options activity, reflecting a highly contested struggle between bullish retail sentiment and significant short interest.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow (NOW) is seeing a surge in community interest as investors weigh its potential as an AI-driven enterprise orchestration layer against ongoing volatility in the software sector. While some market participants are expressing concerns over high valuations and broader SaaS fatigue, others are actively accumulating shares on pullbacks, betting that ServiceNow's deep integration into Fortune 500 workflows positions it to benefit significantly from long-term enterprise AI adoption.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is surging as the market reacts to a strong earnings report that highlights the company's first-ever quarterly profit, accelerated user growth, and successful expansion into new consumer spending categories. Community discussion is heavily focused on the stock's massive upside potential compared to its fintech peers, while traders closely monitor the interplay between short interest, institutional accumulation, and looming legal catalysts.

Viridian Therapeutics, Inc. is a biopharmaceutical company that develops medicines for autoimmune and rare diseases. It uses antibody discovery and protein engineering to create new therapies. The company is advancing late-stage IGF-1R therapies for thyroid eye disease (TED) and developing a potential TSHR-targeted treatment for TED and Graves’ disease. In addition, it is developing FcRn inhibitors, including VRDN-006 and VRDN-008, for multiple autoimmune diseases. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.

Viridian Therapeutics Inc

Viridian Therapeutics is surging following the FDA approval of its flagship thyroid eye disease treatment, Lumvoa, which is the first therapy in the class with labeling supported by clinical data for both active and chronic patients. The community is actively discussing the stock's commercial launch potential, its competitive edge over Amgen's Tepezza, and the possibility of a major partnership or acquisition as institutional interest builds.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Invesco QQQ Trust (QQQ) is seeing intense community debate as investors navigate a complex mix of geopolitical escalations in the Middle East, volatility in global semiconductor markets, and active speculation around potential weekend market manipulation. Traders are closely monitoring key support levels and sector rotation trends while expressing skepticism toward the sustainability of current AI-driven valuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Humanoid Robots the Next Trillion-Dollar AI Theme? ETFs in Focus

As the focus shifts from digital intelligence to physical intelligence, physical AI may be the next multi-trillion-dollar opportunity. These ETFs offer a way in.

Mobileye Global Shares Rally On $900M Mentee Robotics Deal

Equity

Mobileye will pay $612 million in cash and the rest in Class A common shares for humanoid robots the company. 

Humanoid Robot ETFs: Positioning for the Next Tech Revolution

Here's what you need to know about investing in the future of robotics.

KraneShares Trust - KraneShares Global Humanoid Robotics and Physical AI Index ETF

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

KOIDKraneShares Global Humanoid and Embodied Intelligence Index ETF

Latest KOID News